SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Escalating geopolitical tensions in the Middle East, including drone strikes on a major Saudi oil refinery and fears of a Strait of Hormuz disruption, are driving conversation around Indonesia Energy Corp. The community highlights the stock's low float and potential for a short squeeze, recalling its significant moves during prior global energy market volatility.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending following a trading halt prompted by its acquisition of key BrewDog assets and a new U.S. licensing deal with Carlsberg, igniting investor debate. While some hail these beverage sector moves as strategic expansion ahead of potential cannabis rescheduling, many criticize management's past acquisitions and express concern over potential dilution.

AeroVironment, Inc. engages in the design, development, and production of multi-domain robotic systems and related services for government agencies and businesses. It operates through the following business segments: UnCrewed Systems, Loitering Munitions Systems, and MacCready Work. The UnCrewed Systems segment focuses primarily on small UAS products designed to operate reliably at lower altitudes in a wide range of environmental conditions. The Loitering Munitions Systems segment focuses primarily on tube-launched aircraft that deploy with the push of a button, fly at higher speeds than small UAS products, and perform either effects delivery or reconnaissance missions, and related support services including training, spare parts, product repair, and product replacement. The MacCready Works segment focuses on customer-funded research and development in the areas of HAPS, robotics, sensors, software analytics, data intelligence, and connectivity. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is trending amid significant volatility, recently impacted by an earnings miss and a government contract renegotiation, which some in the community view as an overreaction. Nevertheless, sustained discussions highlight AVAV as a crucial drone technology leader, positioned to benefit from escalating global defense spending and bolstered by recent positive analyst coverage.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings (RCAT) is trending amid heightened Middle East tensions and reports of increased drone warfare, fueling speculation about rising demand for its defense drone solutions. The community is actively discussing the stock's potential for defense contracts, including its involvement in the Drone Dominance Gauntlet, alongside ongoing debates about its revenue trajectory and susceptibility to short squeezes.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas is trending following its $10 million strategic investment and partnership with World View to develop multi-domain intelligence, surveillance, and reconnaissance solutions for defense. The community is actively discussing how this positions the company to benefit from escalating global demand for drone and counter-drone technologies, amplified by high short interest fueling squeeze speculation.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global (VG) is sharply trending after a strong Q4 earnings report highlighted triple-digit revenue growth and a new LNG supply agreement. The community is abuzz with expectations of a major short squeeze, driven by escalating geopolitical tensions affecting global LNG supplies and a consensus that the stock remains significantly undervalued amidst growing demand for U.S. energy.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending amid intensifying interest in optical interconnects following major industry investments, with the community highly anticipating its disruptive wafer-scale technology to be pivotal for next-gen AI data centers and expecting imminent partnership announcements from 'even bigger' players.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending after announcing positive Phase 3 SOL-1 trial results for AXPAXLI in wet AMD, demonstrating superiority over Eylea and offering a significantly reduced treatment burden, which the community sees as a potential "game-changer." Despite a market sell-off, investors are actively discussing high analyst price targets and persistent acquisition rumors from Sanofi, anticipating further upside as detailed data is presented at upcoming conferences and a regulatory filing approaches.

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is trending as recent US-Israeli strikes on Iran and subsequent regional retaliation ignite community discussions over potential disruptions to global oil supply, especially concerning the Strait of Hormuz, driving speculation of significantly higher oil prices and market volatility.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is a top trending stock as escalating Middle East tensions, including reported closures of the Strait of Hormuz and attacks on major oil and LNG facilities, ignite fervent community discussion. Traders are sharply divided on whether these supply disruptions will lead to a sustained energy price rally, significantly benefiting XOM, or if the initial surge will quickly fade.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zymeworks Q4 Earnings Call Highlights

Zymeworks (NASDAQ:ZYME) executives used the company's fourth-quarter 2025 results call to highlight updated clinical data for its partnered HER2 antibody zanidatamab, outline a new royalty-backed...

Zymeworks Inc. (ZYME) Reports Q4 Loss, Lags Revenue Estimates

Zymeworks (ZYME) delivered earnings and revenue surprises of -58.64% and -88.23%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Zymeworks (NASDAQ:ZYME) Releases Earnings Results, Misses Estimates By $0.20 EPS

Zymeworks (NASDAQ:ZYME - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.55) EPS for the quarter, missing analysts' consensus estimates of ($0.35) by ($0.20...

Zymeworks Inc. Q4 Loss Widens

(RTTNews) - Zymeworks Inc. (ZYME) announced Loss for its fourth quarter of -$41.209 million...

Zymeworks Secures $250 Mln Royalty Funding Deal With Royalty Pharma

(RTTNews) - Zymeworks Inc. (ZYME), a clinical-stage biopharmaceutical company, on Monday entered into a $250 million royalty funding agreement with Royalty Pharma plc (RPRX), a buyer of...

Earnings Breakdown: Zymeworks Q4

A Look Ahead: Zymeworks's Earnings Forecast

Alkermes (ALKS) Q4 Earnings and Revenues Top Estimates

Alkermes (ALKS) delivered earnings and revenue surprises of +7.80% and +1.21%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Year

Key PointsRedmile Group sold 3,214,096 ZYME shares, estimated at $70.10 million based on quarterly average prices...

Zymeworks Inc. (NASDAQ:ZYME) Given Consensus Recommendation of "Buy" by Brokerages

Shares of Zymeworks Inc. (NASDAQ:ZYME - Get Free Report) have been given an average recommendation of "Buy" by the seven research firms that are currently covering the company, Marketbeat reports...

$ZYME Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of -$0.55 down -77.42% YoY
• Reported revenue of $2.52M down -91.90% YoY
• Zymeworks expects approximately $300M in adjusted gross operating expenditures (non-GAAP) over three years ending December 31, 2028. Zymeworks anticipates cash resources, including $440M in milestones, to fund operations beyond 2028.

Stocktwits

Zymeworks Inc

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of -$0.55 down -77.42% YoY
• Reported revenue of $2.52M down -91.90% YoY
• Zymeworks expects approximately $300M in adjusted gross operating expenditures (non-GAAP) over three years ending December 31, 2028. Zymeworks anticipates cash resources, including $440M in milestones, to fund operations beyond 2028.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Zanidatamab's unique binding properties result in multiple mechanisms of action that may enable it to address unmet need in patient populations with HER2-expressing cancers. The company was founded on September 8, 2003 and is headquartered in Middletown, DE.

Current Price	$23.29
Prev Close	$23.81
Open	$23.30
Dividend Yield	0.00%
50-Day Moving Average	$24.10
Beta	0.91
Avg. Volume	970,910.05
PE Ratio	-27.50

52-Week High	$28.49
52-Week Low	$9.03
Market Capitalization	$1.76B
EPS (Annual)	-$1.62
Price to Book	5.51
Revenue Per Employee	$266,797.20

ZYME
Zymeworks Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ZYME News

ZYMEZymeworks Inc